Search by Drug Name or NDC

    NDC 49035-0560-08 Cold Multi-Symptom 325; 10; 5 mg/1; mg/1; mg/1 Details

    Cold Multi-Symptom 325; 10; 5 mg/1; mg/1; mg/1

    Cold Multi-Symptom is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by Wal-Mart Stores Inc. The primary component is ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE.

    Product Information

    NDC 49035-0560
    Product ID 49035-560_0cccc601-0ef0-45d5-b138-e48e5de99380
    Associated GPIs 43996903400320
    GCN Sequence Number 060981
    GCN Sequence Number Description d-methorphan/PE/acetaminophen TABLET 10-5-325MG ORAL
    HIC3 B4M
    HIC3 Description NON-OPIOID ANTITUSSIVE-DECONGESTANT-ANALGESIC COMB
    GCN 27135
    HICL Sequence Number 008885
    HICL Sequence Number Description DEXTROMETHORPHAN HBR/PHENYLEPHRINE HCL/ACETAMINOPHEN
    Brand/Generic Generic
    Proprietary Name Cold Multi-Symptom
    Proprietary Name Suffix Daytime
    Non-Proprietary Name Acetaminophen, Dextromethorphan HBr, and Phenylephrine HCl
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 325; 10; 5
    Active Ingredient Units mg/1; mg/1; mg/1
    Substance Name ACETAMINOPHEN; DEXTROMETHORPHAN HYDROBROMIDE; PHENYLEPHRINE HYDROCHLORIDE
    Labeler Name Wal-Mart Stores Inc
    Pharmaceutical Class Adrenergic alpha1-Agonists [MoA], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC], Uncompetitive NMDA Receptor Antagonists [MoA], alpha-1 Adrenergic Agonist [EPC]
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part341
    Listing Certified Through n/a

    Package

    NDC 49035-0560-08 (49035056008)

    NDC Package Code 49035-560-08
    Billing NDC 49035056008
    Package 2 BLISTER PACK in 1 CARTON (49035-560-08) / 12 TABLET in 1 BLISTER PACK
    Marketing Start Date 2008-03-29
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 9ecafbb2-00b3-4abb-aecf-9595f680ff46 Details

    Revised: 10/2020